These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 863152)

  • 21. Change offers children the best of both polio vaccines. Oklahoma State Department of Health and the Centers for Disease Control and Prevention.
    J Okla State Med Assoc; 1997 Apr; 90(4):142-9. PubMed ID: 9143160
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy of three doses of oral polio immunization beginning within the first four days of life.
    Bhatawdekar AM; Kumta NB; Dave KH; Bharucha BA
    Indian Pediatr; 1990 Sep; 27(9):911-4. PubMed ID: 2286433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Primary immunization and booster vaccination against polio].
    Müller HE
    Dtsch Med Wochenschr; 1995 May; 120(21):776. PubMed ID: 7781504
    [No Abstract]   [Full Text] [Related]  

  • 25. [Observations on children vaccinated orally with triple anti-poliomyelitis vaccine].
    Kocińska-Sypczyńska D
    Przegl Epidemiol; 1976; 30(1):53-8. PubMed ID: 179117
    [No Abstract]   [Full Text] [Related]  

  • 26. [The epidemic of paralytic poliomyelitis at Cap Bon (Tunisia) in 1971; epidemiological considerations; relative failure of vaccination].
    Beghin D; Thiry L; De Bruycker J; Ezzili M
    Brux Med; 1973 Mar; 53(3):159-68. PubMed ID: 4737258
    [No Abstract]   [Full Text] [Related]  

  • 27. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.
    Abbink F; Buisman AM; Doornbos G; Woldman J; Kimman TG; Conyn-van Spaendonck MA
    J Infect Dis; 2005 Mar; 191(6):990-9. PubMed ID: 15717277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotype-specific mucosal immune response and subsequent poliovirus replication in vaccinated children.
    Samoilovich E; Roivainen M; Titov LP; Hovi T
    J Med Virol; 2003 Oct; 71(2):274-80. PubMed ID: 12938203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Unsatisfactory seroconversion in poliomyelitis and chickenpox in children immunized with 5 antigens].
    González-Cortés A; Zárate-Aquino ML; Fernández de Castro D; Marroquín H; Guzmán-Bahena J
    Gac Med Mex; 1979 Apr; 115(4):187-95. PubMed ID: 378751
    [No Abstract]   [Full Text] [Related]  

  • 30. Antipoliomyelitis program in Brazil; a erologic study of immunity levels.
    de Brito Bastos NC; Carvalho Filho ES de+CARVALHOAAFILHO ES; Schatzmayr H; Homma A; Chaves J
    Bull Pan Am Health Organ; 1974; 8(1):54-65. PubMed ID: 4423450
    [No Abstract]   [Full Text] [Related]  

  • 31. [Post-vaccination anti-poliomyelitis seroprevalence in an urban setting in Abidjan].
    Akoua-Koffi G; Thonnon J; Kouassi-Renaud M; Dosso M; Ehouman A
    Bull Soc Pathol Exot; 1995; 88(3):117-20. PubMed ID: 8555765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A comparison of the effectiveness of mass immunization campaign of trivalent oral poliovirus vaccine (TOPV) by epidemiological serosurvey. Shandong Collaborating Group for Poliomyelitis Control and Surveillance, Jinan, Shandong].
    Xu A
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):261-4. PubMed ID: 1338626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of neutralized antibody level of the poliomyelitis in healthy population in Fujian province].
    He AH; Wang H; Yang XH; Xu JY; Zhang HR; Huang LF
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Oct; 24(5):352-4. PubMed ID: 21280322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Humoral poliomyelitis immunity in children inoculated with a live poliomyelitis vaccine].
    Kaplan AS; Vasilevskaia NI; Kozhevnikov IN
    Vopr Virusol; 1984; 29(2):251-3. PubMed ID: 6328770
    [No Abstract]   [Full Text] [Related]  

  • 36. Pulse polio Immunisation Programme (PPIP).
    Zacharias PT
    J Indian Med Assoc; 2000 Apr; 98(4):191. PubMed ID: 11016190
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunization status of hospitalized children with acute paralytic poliomyelitis.
    John TJ
    Indian Pediatr; 1996 Mar; 33(3):246-7. PubMed ID: 8772852
    [No Abstract]   [Full Text] [Related]  

  • 38. [Recent recommendations of the National Committee on Vaccines regarding polio immunization].
    Caraffa De Stefano D; Vellucci L
    Ann Ig; 2002; 14(4 Suppl 5):81-4. PubMed ID: 12389296
    [No Abstract]   [Full Text] [Related]  

  • 39. Booster effect of Sabin poliomyelitis vaccine.
    Teplý V; Srámová H; Svandová E
    Bull World Health Organ; 1976; 54(6):681-4. PubMed ID: 1088514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding routine poliovirus vaccination.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Aug; 58(30):829-30. PubMed ID: 19661857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.